Saturday 17 October 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024. In the quarter to June 2026, revenue grew 3.42%, EPS fell 84.8%, free cash flow grew 103.3% and total debt rose 16.0%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

232.65 2.70 −1.15%

Follow BIIB

Alert me

Market cap: $34.8B
P/E: 41.0×
Fwd P/E: 31.5×
Dividend yield: —
F-score: 4/9
Altman Z: 3.13
Beneish M: −2.67
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	12.75	19.93	19.61	38.04
P/S ratio Full definition →		2.04	2.61	2.72	3.18
P/FCF ratio Full definition →		9.08	12.77	11.24	12.56
P/Operating CF Full definition →		16.14	50.37	41.81	71.09
P/B ratio Full definition →		1.13	1.41	1.45	1.69
Price to Tangible BV Full definition →		8.61	9.97	8.68	0.00
EV/Sales Full definition →		2.27	2.86	2.92	3.78
EV/EBITDA Full definition →		7.23	9.62	9.57	14.71
EV/Operating CF Full definition →		9.32	12.82	11.19	13.17
EV/FCF Full definition →		10.11	13.99	12.07	14.93
Quick Ratio Full definition →		1.62	1.54	1.88	0.81
Current Ratio Full definition →		2.72	2.68	3.06	1.87
Net Debt/EBITDA Full definition →		2.72	5.84	2.83	10.18
Debt/Assets Full definition →		21.52%	21.35%	21.33%	22.72%
Debt/Equity Full definition →		0.35	0.34	0.34	0.39
Asset Turnover Full definition →		0.35	0.34	0.35	0.33
Operating CF/Net income Full definition →		2.73	(10.47)	2.02	4.60
Capex/Depreciation Full definition →		(0.20)	(0.19)	(0.16)	(0.40)
Research and Development Expense of Revenue Full definition →		17.21%	22.35%	21.75%	19.36%
Selling, General and Administrative Expense of Revenue Full definition →		23.47%	29.94%	24.51%	25.94%
Intangible Assets out of Total Assets Full definition →		0.54	0.53	0.53	0.64
Share Based Compensation of Revenue Full definition →		2.97%	2.61%	3.39%	2.83%
Graham Net Nets Full definition →		(0.10)	(0.09)	(0.06)	(0.19)
Graham Number Full definition →		175.25	157.35	163.27	127.71
Earnings Yield Full definition →		7.85%	5.02%	5.10%	2.63%
Free Cash Flow Yield Full definition →		11.02%	7.83%	8.90%	7.96%
Revenue per Share Full definition →		17.29	15.56	16.83	18.52
Operating CF per Share Full definition →		8.68	3.49	4.39	3.04
Capex per Share Full definition →		(0.35)	(0.41)	(0.35)	(1.19)
Free Cash Flow per Share Full definition →		8.33	3.08	4.04	1.85
Cash per Share Full definition →		27.02	26.05	29.09	8.70
Shareholders Equity per Share Full definition →		124.20	124.62	126.71	127.61
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		124.20	124.62	126.71	127.61
Free Cash Flow Full definition →		1,221.00	451.70	594.30	273.00
Working Capital Full definition →		5,646.60	5,624.70	6,191.50	3,388.60
Capital Expenditures Full definition →		(51.50)	(60.20)	(51.20)	(175.90)
Net Current Asset Value Full definition →		(2,063.40)	(2,208.60)	(1,641.00)	(5,932.90)
EV/EBIT Full definition →		10.37	15.17	15.42	30.63
Capex to Sales Full definition →		0.02	0.03	0.02	0.06
Price to Operating Income Full definition →		9.31	13.85	14.36	25.78
Other line items
Average Receivables Full definition →		1,455.15	1,373.60	1,682.85	1,754.90
Average Payables Full definition →		417.90	428.10	375.00	406.15
Average Inventory Full definition →		2,339.30	2,314.30	2,111.45	2,329.30
Average Assets Full definition →		28,760.35	28,744.40	28,758.10	30,208.40
Average Common Equity Full definition →		17,283.20	17,486.40	17,815.20	18,241.00

Show all line items

Columns are period end dates

Stockrow Weekly